Skip to content

Effects of of glucose-insulin-potassium on uterine contractions pain after cesarean section: a randomized, controlled, double-blind clinical study

Effects of of glucose-insulin-potassium on uterine contractions pain after cesarean section: a randomized, controlled, double-blind clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041607
Enrollment
Unknown
Registered
2021-01-01
Start date
2020-12-30
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

experimental group:glucose-insulin-potassium
control group:Normal saline

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Aged 20-40 years; 2) ASA I - II; 3) Patients with single-birth pregnancy; 4) Patients who voluntarily sign informed consent forms for cesarean section operation and postoperative self-control analgesia; 5) Willing to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) A history of mental illness or treatment with psychotropic drugs; 2) Gestational diabetes mellitus and hypertension complicated with severe eclampsia; 3) A known prenatal history of depression or bipolar disorder; 4) Suicidal tendency or history of suicide; 5) A history of drug, alcohol or opioid abuse; 6) Being or receiving monoamine oxidase (MAO) inhibitor treatment in the past 2 weeks; 7) Allergic to opioids or tramadol; 8) Central nervous system diseases such as epilepsy; 9) Other serious diseases of the heart, brain, liver, kidney and hematopoietic system; 10) Taking other experimental drugs or participating in other clinical trials three months before the inclusion in the study; 11) Cannot cooperate with the study for any reason or the researcher considers it inappropriate to be included in this study.

Design outcomes

Primary

MeasureTime frame
pain;

Countries

China

Contacts

Public ContactLi Hong

The Second Affiliated Hospital of Army Medical University

472151685@qq.com+86 23-68774983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026